Inventor
LORENZ KATRIN
DE24 patents
⚠️ This page may combine multiple inventors who share the name “LORENZ KATRIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANOFI SA
17 patentsUS9745360B2Aug 29, 2017
Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists
SANOFI SA14 citations92
US9750788B2Sep 5, 2017
Non-acylated exendin-4 peptide analogues
SANOFI SA11 citations84
US9789165B2Oct 17, 2017
Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists
SANOFI SA4 citations73
US9751926B2Sep 5, 2017
Dual GLP-1/GIP receptor agonists
SANOFI SA4 citations73
US9670261B2Jun 6, 2017
Functionalized exendin-4 derivatives
SANOFI SA2 citations73
US10538567B2Jan 21, 2020
Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists
SANOFI SA2 citations72
US10519211B2Dec 31, 2019
Compounds as peptidic GLP1/glucagon/GIP receptor agonists
SANOFI SA2 citations72
US9982029B2May 29, 2018
Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists
SANOFI SA2 citations72
US9771406B2Sep 26, 2017
Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4
SANOFI SA4 citations72
US9284333B2Mar 15, 2016
Fused pyrroledicarboxamides and their use as pharmaceuticals
SANOFI SA5 citations71
US10253079B2Apr 9, 2019
Functionalized Exendin-4 derivatives
SANOFI SA0 citations52
US9884860B2Feb 6, 2018
Fused pyrroledicarboxamides and their use as pharmaceuticals
SANOFI SA1 citations51
US9598410B2Mar 21, 2017
Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicament, and pharmaceutical preparations comprising them
SANOFI SA0 citations51
US12054551B2Aug 6, 2024
FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof with GLP-1R agonistic peptides
SANOFI SA0 citations46
US10806797B2Oct 20, 2020
Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate
SANOFI SA0 citations39
US9776991B2Oct 3, 2017
Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase
SANOFI SA0 citations36
US9540391B2Jan 10, 2017
Isomannide derivatives as inhibitors of soluble epoxide hydrolase
SANOFI SA0 citations33
PLETTENBURG OLIVER
6 patentsUS8742116B2Jun 3, 2014
Cycloalkylamine substituted isoquinolone derivatives
PLETTENBURG OLIVER4 citations71
US8541449B2Sep 24, 2013
Substituted isoquinolines and isoquinolinones as Rho kinase inhibitors
PLETTENBURG OLIVER3 citations60
US8399482B2Mar 19, 2013
6-substituted isoquinolines and isoquinolinones
PLETTENBURG OLIVER1 citations51
US8772492B2Jul 8, 2014
Substituted isoquinoline and isoquinolinone derivatives
PLETTENBURG OLIVER0 citations39
US8524737B2Sep 3, 2013
Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives
PLETTENBURG OLIVER0 citations39
US8710077B2Apr 29, 2014
Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
PLETTENBURG OLIVER0 citations35